|
Market Closed -
OTC Markets
10:01:08 2021-11-05 EDT
|
5-day change | 1st Jan Change | ||
| 7.151 USD | -2.19% |
|
-.--% | - |
| 08-20 | Will Moderna Wake Up the Health Care Sector? | |
| 06-11 | IShares IV Public Limited Company Announces Interim Distribution for 2026, Payable on 30 June 2026 | CI |
Investment objective
The iShares Nasdaq US Biotechnology UCITS ETF seeks to track the investment results of an index composed of biotechnology and pharmaceutical equities listed on the NASDAQ.
Off-Hours Price |
Change |
YTD change |
Weight | ||
|---|---|---|---|---|---|
| 146.41USD | +1.87% | +19.28% | 9.34% | ||
| 519.51USD | +0.79% | +14.59% | 9.05% | ||
| 381.50USD | +1.10% | +16.56% | 8.97% | ||
| 793.74USD | +1.57% | +2.83% | 5.98% | ||
| 249.99USD | +0.53% | -37.13% | 3.29% | ||
| 125.30USD | -3.18% | -28.01% | 2.4% | ||
| 217.36USD | +0.10% | +23.51% | 2.07% | ||
| 502.70USD | +1.12% | +3.17% | 1.63% | ||
| 146.69USD | +1.89% | +397.42% | 1.52% | ||
Description
| IE00BYXG2H39 | |
|---|---|
| Total Expense Ratio | 0.0035 |
| Asset Class | Stocks |
| Geographical Zones | |
| Sector | |
| Currency | |
| Provider | |
| Underlying | NASDAQ Biotechnology Net Total Return Index - USD |
| Autres ETFs | |
Features and characteristics
| Dividend Policy | Capitalisation |
|---|---|
| Replication Method | Physique |
| Jurisdiction | |
| Date of creation |
2017-10-18
|
| Geographical Focus |
AuM evolution - 2026-08-11
| AuM (USD) | 1.24B |
|---|---|
| AuM 1M | 1.24B |
| AuM 3 months | 1.24B |
| AuM 6 months | 1.24B |
| AuM 12 months | 1.24B |
- Stock Market
- ETF
- IVBUF ETF
Select your edition
All financial news and data tailored to specific country editions

















